Ionis Pharmaceuticals Inc banner

Ionis Pharmaceuticals Inc
F:ISI

Watchlist Manager
Ionis Pharmaceuticals Inc Logo
Ionis Pharmaceuticals Inc
F:ISI
Watchlist
Price: 67.98 EUR 5.82% Market Closed
Market Cap: €9.9B

Wall St Price Targets

ISI Price Targets Summary
Ionis Pharmaceuticals Inc

Wall Street analysts forecast ISI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ISI is 82.68 EUR with a low forecast of 37.77 EUR and a high forecast of 110.96 EUR.

Lowest Forecast
Price Target
37.77 EUR
44% Downside
Average Forecast
Price Target
82.68 EUR
22% Upside
Highest Forecast
Price Target
110.96 EUR
63% Upside
Ionis Pharmaceuticals Inc Competitors:
Price Targets
SMCP
SMCP SA
79% Upside
VERK
Verkkokauppa.com Oyj
35% Upside
LAND
Gladstone Land Corp
27% Upside
TTD
Trade Desk Inc
33% Upside

Revenue
Forecast

19% / Year
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
5%
Average Beat
19% / Year
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
5%
Average Beat

Over the last 13 years, the compound annual growth rate for Revenue has been 19%. The projected CAGR for the next 8 years is 25%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-31%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-31%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ISI's stock price target?
Price Target
82.68 EUR

According to Wall Street analysts, the average 1-year price target for ISI is 82.68 EUR with a low forecast of 37.77 EUR and a high forecast of 110.96 EUR.

What is the Revenue forecast for Ionis Pharmaceuticals Inc?
Projected CAGR
25%

Over the last 13 years, the compound annual growth rate for Revenue has been 19%. The projected CAGR for the next 8 years is 25%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett